|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/468 | (2013.01) | ||
| C07K 16/46 | (2006.01) | ||
| C07K2317/515 | (2013.01) | ||
| C07K2317/73 | (2013.01) | ||
| C07K 16/2863 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 38/00 | (2013.01) |
| (11) | Patento numeris | 3448890 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17724504.0 |
| Europos patento paraiškos padavimo data | 2017-04-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-03-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-07-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/060280 |
| Data | 2017-04-28 |
| (87) | Numeris | WO 2017/186950 |
| Data | 2017-11-02 |
| (30) | Numeris | Data | Šalis |
| 16305496 | 2016-04-28 | EP |
| (72) |
ZHUKOVSKY, Eugene , FR
LEGER, Olivier , FR
GERARD, Pierre-Emmanuel , FR
PELEGRIN, André , FR
LARBOURET, Christel , FR
|
| (73) |
Biomunex Pharmaceuticals ,
29 rue du Faubourg Saint Jacques, 75014 Paris,
FR
INSERM (Institut National de la Santé et de la Recherche Médicale) , 101, rue de Tolbiac, 75013 Paris, FR Université de Montpellier , 163, rue Auguste Broussonnet, 34090 Montpellier, FR Institut Régional du Cancer de Montpellier (ICM) , 208 Rue des Apothicaires Parc Euromédecine, 34298 Montpellier Cedex 5, FR |
| (54) | BISPECIFIC ANTIBODIES TARGETING EGFR AND HER2 |
| BISPECIFIC ANTIBODIES TARGETING EGFR AND HER2 |